Prime Medicine PRME
NASDAQ PRME
$3.05 -0.01 (-0.33%)
As of: Oct 1, 2026 · 11:47 AM EDT

Prime Medicine (PRME) Change in Receivables (2024 - 2025)

Updated

Prime Medicine's Change in Receivables came in at -$120,000 for Q3 2025, compared with $55 million a year earlier.

Analysis

Prime Medicine (PRME) Change in Receivables (2024 - 2025) Analysis & Trends

Going back to Q3 2024, Prime Medicine's Change in Receivables data covers 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Prime Medicine 553.06 Mn 553.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -120,000.00
Jun 30, 2025 103,000.00
Mar 31, 2025 17,000.00
Sep 30, 2024 55.00 Mn
API Access

Prime Medicine Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=PRME&period=max&api_key=YOUR_API_KEY